Literature DB >> 21343292

Mixed dimers of insulin-degrading enzyme reveal a cis activation mechanism.

Eun Suk Song1, David W Rodgers, Louis B Hersh.   

Abstract

Insulin-degrading enzyme (IDE) exists primarily as a dimer being unique among the zinc metalloproteases in that it exhibits allosteric kinetics with small synthetic peptide substrates. In addition the IDE reaction rate is increased by small peptides that bind to a distal site within the substrate binding site. We have generated mixed dimers of IDE in which one or both subunits contain mutations that affect activity. The mutation Y609F in the distal part of the substrate binding site of the active subunit blocks allosteric activation regardless of the activity of the other subunit. This effect shows that substrate or small peptide activation occurs through a cis effect. A mixed dimer composed of one wild-type subunit and the other subunit containing a mutation that neither permits substrate binding nor catalysis (H112Q) exhibits the same turnover number per active subunit as wild-type IDE. In contrast, a mixed dimer in which one subunit contains the wild-type sequence and the other contains a mutation that permits substrate binding, but not catalysis (E111F), exhibits a decrease in turnover number. This indicates a negative trans effect of substrate binding at the active site. On the other hand, activation in trans is observed with extended substrates that occupy both the active and distal sites. Comparison of the binding of an amyloid β peptide analog to wild-type IDE and to the Y609F mutant showed no difference in affinity, indicating that Y609 does not play a significant role in substrate binding at the distal site.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21343292      PMCID: PMC3077586          DOI: 10.1074/jbc.M110.191668

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Characterization of the binding of the fluorescent ATP analog TNP-ATP to insulysin.

Authors:  Hongbing Yao; Louis B Hersh
Journal:  Arch Biochem Biophys       Date:  2006-05-06       Impact factor: 4.013

2.  Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease.

Authors:  K Shii; R A Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  In vivo association of [125I]-insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-linking and immunoprecipitation with a monoclonal antibody.

Authors:  J Hari; K Shii; R A Roth
Journal:  Endocrinology       Date:  1987-02       Impact factor: 4.736

4.  Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism.

Authors:  Yuequan Shen; Andrzej Joachimiak; Marsha Rich Rosner; Wei-Jen Tang
Journal:  Nature       Date:  2006-10-11       Impact factor: 49.962

5.  ATP effects on insulin-degrading enzyme are mediated primarily through its triphosphate moiety.

Authors:  Eun Suk Song; Maria Aparecida Juliano; Luiz Juliano; Michael G Fried; Steven L Wagner; Louis B Hersh
Journal:  J Biol Chem       Date:  2004-10-19       Impact factor: 5.157

6.  Identification of gamma-endorphin-generating enzyme as insulin-degrading enzyme.

Authors:  A Safavi; B C Miller; L Cottam; L B Hersh
Journal:  Biochemistry       Date:  1996-11-12       Impact factor: 3.162

7.  Mutation of active site residues of insulin-degrading enzyme alters allosteric interactions.

Authors:  Eun Suk Song; Abigail Daily; Michael G Fried; Maria Aparecida Juliano; Luiz Juliano; Louis B Hersh
Journal:  J Biol Chem       Date:  2005-03-03       Impact factor: 5.157

8.  Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death.

Authors:  Malcolm A Leissring; Wesley Farris; Alice Y Chang; Dominic M Walsh; Xining Wu; Xiaoyan Sun; Matthew P Frosch; Dennis J Selkoe
Journal:  Neuron       Date:  2003-12-18       Impact factor: 17.173

9.  Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo.

Authors:  Bonnie C Miller; Elizabeth A Eckman; Kumar Sambamurti; Nicole Dobbs; K Martin Chow; Christopher B Eckman; Louis B Hersh; Dwain L Thiele
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

10.  Substrate activation of insulin-degrading enzyme (insulysin). A potential target for drug development.

Authors:  Eun-Suk Song; Maria Aparecida Juliano; Luiz Juliano; Louis B Hersh
Journal:  J Biol Chem       Date:  2003-10-02       Impact factor: 5.157

View more
  7 in total

Review 1.  Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.

Authors:  Wei-Jen Tang
Journal:  Trends Endocrinol Metab       Date:  2015-12-02       Impact factor: 12.015

2.  Anion activation site of insulin-degrading enzyme.

Authors:  Nicholas Noinaj; Eun Suk Song; Sonia Bhasin; Benjamin J Alper; Walter K Schmidt; Louis B Hersh; David W Rodgers
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

3.  Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo.

Authors:  Timothy B Durham; James L Toth; Valentine J Klimkowski; Julia X C Cao; Angela M Siesky; Jesline Alexander-Chacko; Ginger Y Wu; Jeffrey T Dixon; James E McGee; Yong Wang; Sherry Y Guo; Rachel Nicole Cavitt; John Schindler; Stefan J Thibodeaux; Nathan A Calvert; Michael J Coghlan; Dana K Sindelar; Michael Christe; Vladislav V Kiselyov; M Dodson Michael; Kyle W Sloop
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

4.  Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme.

Authors:  Lauren A McCord; Wenguang G Liang; Evan Dowdell; Vasilios Kalas; Robert J Hoey; Akiko Koide; Shohei Koide; Wei-Jen Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-06       Impact factor: 11.205

5.  Deletion of the fission yeast homologue of human insulinase reveals a TORC1-dependent pathway mediating resistance to proteotoxic stress.

Authors:  Clémentine Beuzelin; Irini Evnouchidou; Pascal Rigolet; Anne Cauvet-Burgevin; Pierre-Marie Girard; Delphine Dardalhon; Slobodan Culina; Abdelaziz Gdoura; Peter van Endert; Stefania Francesconi
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

6.  Identification of the allosteric regulatory site of insulysin.

Authors:  Nicholas Noinaj; Sonia K Bhasin; Eun Suk Song; Kirsten E Scoggin; Maria A Juliano; Luiz Juliano; Louis B Hersh; David W Rodgers
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

7.  An Extended Polyanion Activation Surface in Insulin Degrading Enzyme.

Authors:  Eun Suk Song; Mehmet Ozbil; Tingting Zhang; Michael Sheetz; David Lee; Danny Tran; Sheng Li; Rajeev Prabhakar; Louis B Hersh; David W Rodgers
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.